DE60044119D1 - Reagentien und verfahren zur erkennung von erkrankungen der brust - Google Patents
Reagentien und verfahren zur erkennung von erkrankungen der brustInfo
- Publication number
- DE60044119D1 DE60044119D1 DE60044119T DE60044119T DE60044119D1 DE 60044119 D1 DE60044119 D1 DE 60044119D1 DE 60044119 T DE60044119 T DE 60044119T DE 60044119 T DE60044119 T DE 60044119T DE 60044119 D1 DE60044119 D1 DE 60044119D1
- Authority
- DE
- Germany
- Prior art keywords
- breast
- useful
- diseases
- reagent
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000000481 breast Anatomy 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 206010027454 Metastases to breast Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23471699A | 1999-01-21 | 1999-01-21 | |
| PCT/US2000/001452 WO2000043420A1 (en) | 1999-01-21 | 2000-01-21 | Reagents and methods useful for detecting diseases of the breast |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60044119D1 true DE60044119D1 (de) | 2010-05-20 |
Family
ID=22882506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60044119T Expired - Lifetime DE60044119D1 (de) | 1999-01-21 | 2000-01-21 | Reagentien und verfahren zur erkennung von erkrankungen der brust |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060154291A1 (de) |
| EP (1) | EP1144449B1 (de) |
| JP (1) | JP2002540761A (de) |
| AT (1) | ATE463508T1 (de) |
| CA (1) | CA2358800C (de) |
| DE (1) | DE60044119D1 (de) |
| ES (1) | ES2343103T3 (de) |
| WO (1) | WO2000043420A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6528054B1 (en) | 1998-12-28 | 2003-03-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6680197B2 (en) | 1998-12-28 | 2004-01-20 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6579973B1 (en) | 1998-12-28 | 2003-06-17 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| US6958361B2 (en) * | 1998-12-28 | 2005-10-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US7598226B2 (en) | 1998-12-28 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6586572B2 (en) * | 1998-12-28 | 2003-07-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6573368B2 (en) | 1998-12-28 | 2003-06-03 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| US6844325B2 (en) | 1998-12-28 | 2005-01-18 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| US6518237B1 (en) | 1998-12-28 | 2003-02-11 | Corixa Corporation | Compositions for treatment and diagnosis of breast cancer and methods for their use |
| US6590076B1 (en) * | 1999-04-02 | 2003-07-08 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| CA2392510A1 (en) | 1999-11-30 | 2001-06-07 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
| AU2004230328A1 (en) * | 2003-04-15 | 2004-10-28 | Sanofi Pasteur Limited | Tumor antigens BFA5 for prevention and/or treatment of cancer |
| US8207314B2 (en) * | 2003-05-16 | 2012-06-26 | Sanofi Pasteur Limited | Tumor antigens for prevention and/or treatment of cancer |
| US20100129289A1 (en) * | 2006-05-18 | 2010-05-27 | The Ohio State University Research Foundation | Compositions and methods for the detection of vulnerable plaque |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2804445A1 (de) | 1978-02-02 | 1979-08-09 | Studiengesellschaft Kohle Mbh | Verfahren zur herstellung von magnesiumhydriden |
| US5618695A (en) * | 1995-06-07 | 1997-04-08 | Mayo Foundation For Medical Education And Research | DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells |
| US5736331A (en) * | 1995-07-08 | 1998-04-07 | Schering Corporation | Method for identifying nucleic acids encoding c-fos promoter activating proteins |
| JP4614472B2 (ja) * | 1996-10-31 | 2011-01-19 | アボット・ラボラトリーズ | 乳房の疾患の検出に有用な試薬および方法 |
| WO1998059049A1 (en) * | 1997-06-20 | 1998-12-30 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
| WO1999002559A1 (en) * | 1997-07-07 | 1999-01-21 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
| WO1999025850A1 (en) * | 1997-11-17 | 1999-05-27 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
-
2000
- 2000-01-21 EP EP00903373A patent/EP1144449B1/de not_active Expired - Lifetime
- 2000-01-21 ES ES00903373T patent/ES2343103T3/es not_active Expired - Lifetime
- 2000-01-21 DE DE60044119T patent/DE60044119D1/de not_active Expired - Lifetime
- 2000-01-21 JP JP2000594836A patent/JP2002540761A/ja active Pending
- 2000-01-21 CA CA2358800A patent/CA2358800C/en not_active Expired - Lifetime
- 2000-01-21 AT AT00903373T patent/ATE463508T1/de active
- 2000-01-21 WO PCT/US2000/001452 patent/WO2000043420A1/en not_active Ceased
-
2006
- 2006-02-06 US US11/348,129 patent/US20060154291A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060154291A1 (en) | 2006-07-13 |
| ES2343103T3 (es) | 2010-07-23 |
| JP2002540761A (ja) | 2002-12-03 |
| WO2000043420A1 (en) | 2000-07-27 |
| CA2358800A1 (en) | 2000-07-27 |
| EP1144449B1 (de) | 2010-04-07 |
| CA2358800C (en) | 2015-03-17 |
| EP1144449A1 (de) | 2001-10-17 |
| ATE463508T1 (de) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000056352A3 (en) | Reagents and methods useful for detecting diseases of the prostate | |
| ATE364089T1 (de) | Reagenzien und methoden zum nachweis von erkrankungen der brust | |
| DE60044119D1 (de) | Reagentien und verfahren zur erkennung von erkrankungen der brust | |
| RU2013113439A (ru) | Идентификация опухолеассоциированных антигенов для диагностики и терапии | |
| DE69833572D1 (de) | Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens | |
| CA2395729A1 (en) | NUCLEIC ACIDS, PROTEINS AND ANTIBODIES | |
| DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| WO2002062945A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| JP2010529843A5 (de) | ||
| Vadon-Le Goff et al. | Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases | |
| EA200501197A1 (ru) | Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1 | |
| WO2002064741A3 (en) | Compositions and methods relating to breast specific genes and proteins | |
| ATE449171T1 (de) | Reagentia und verfahren zum nachweis von brustkrankheiten | |
| WO2002040673A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2004050860A3 (en) | Compositions, splice variants and methods relating to colon specific genes and proteins | |
| WO2000041516A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
| WO1999031274A3 (en) | Reagents and methods useful for detecting diseases of the pancreas | |
| KR101751929B1 (ko) | 신규 간암 환자의 소라페닙 저항성 예측 마커 | |
| WO2004053075A3 (en) | Compositions, splice variants and methods relating to breast specific genes and proteins | |
| WO2005017102A3 (en) | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins | |
| WO1999014357A3 (en) | Reagents and methods useful for detecting diseases of the prostate, breast and ovary | |
| WO2001065262A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
| WO2003066877A3 (en) | Compositions and methods relating to hepatic specific genes and proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |